Targeting Protein-Protein Interactions

Date: Tuesday, 19 March 2013 - Wednesday, 20 March 2013
Location: Munich, Germany

Keynote Speakers

Andrei Gartel
Associate Professor, University of Illinois at Chicago

Arthur Olson
Professor, The Scripps Research Institute

Overview

Targeting Protein-Protein Interactions provides a promising channel for the discovery of new drugs. Even though many scientists are drawn towards genomics, more and more are investigating this fascinating discipline which can provide detailed information on suitable drug targets for novel therapeutics. From competitive antagonism to allosteric inhibition, versatile protein interactions offer an array of targets for sophisticated drugs. Our speakers will provide delegates with innovative means to enhance this challenging process.

Session Sponsors

Agenda Topics

Novel Tools Applied to Protein-Protein Interaction
Post Translational Modifications
Protein-Protein Interaction in Disease and Drug Development
Therapeutic Applications

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
Rudolf Allemann, Distinguished Research Professor, Cardiff University
Carol Austin, Group Leader, Selcia Limited
James Bibb, Associate Professor, University of Texas Southwestern Medical Center
Tomasz Cierpicki, Assistant Professor, University of Michigan
Peter Crowley, Professor, National University of Ireland Galway
Ian Hardcastle, Lecturer, Newcastle University
Volkhard Helms, Chair of Computational Biology, Universitat des Saarlandes
Moses Prabu, Group Leader, Protein Sciences, Berg Pharma
Philippe Roche, Senior Scientist, National Center for Scientific Research
Ilya Vakser, Professor, The University of Kansas
Chiara Valenzano, Post-Doctoral Researcher, University of Cambridge
Arnout Voet, Researcher, RIKEN
Andrew Wilson, Reader in Synthetic Chemistry, University of Leeds